2017 Q3 Form 10-Q Financial Statement

#000107997317000642 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $310.0K $420.0K
YoY Change -26.19% -17.65%
% of Gross Profit
Research & Development $106.7K $112.2K
YoY Change -4.9% -16.54%
% of Gross Profit
Depreciation & Amortization $436.00 $502.00
YoY Change -13.15% -99.34%
% of Gross Profit
Operating Expenses $419.3K $537.4K
YoY Change -21.98% -25.18%
Operating Profit -$419.3K -$537.4K
YoY Change -21.98% -25.18%
Interest Expense $98.44K $92.76K
YoY Change 6.12% -19.16%
% of Operating Profit
Other Income/Expense, Net -$98.44K -$92.76K
YoY Change 6.12% -19.16%
Pretax Income -$520.0K -$630.0K
YoY Change -17.46% -24.1%
Income Tax
% Of Pretax Income
Net Earnings -$517.7K -$630.2K
YoY Change -17.85% -24.35%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$21.60K -$26.76K
COMMON SHARES
Basic Shares Outstanding 24.07M 23.54M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $60.00K
YoY Change -100.0% -66.67%
Cash & Equivalents $2.413K $64.42K
Short-Term Investments
Other Short-Term Assets $0.00 $20.00K
YoY Change -100.0% -33.33%
Inventory
Prepaid Expenses $2.856K $15.90K
Receivables
Other Receivables $2.380K $1.000K
Total Short-Term Assets $7.649K $81.32K
YoY Change -90.59% -74.59%
LONG-TERM ASSETS
Property, Plant & Equipment $2.756K $3.757K
YoY Change -26.64% -99.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.756K $3.757K
YoY Change -26.64% -99.8%
TOTAL ASSETS
Total Short-Term Assets $7.649K $81.32K
Total Long-Term Assets $2.756K $3.757K
Total Assets $10.41K $85.08K
YoY Change -87.77% -96.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $920.0K $820.0K
YoY Change 12.2% -43.06%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $110.0K $0.00
YoY Change
Long-Term Debt Due $8.850M $8.620M
YoY Change 2.67% 11.23%
Total Short-Term Liabilities $12.24M $11.13M
YoY Change 10.06% 9.93%
LONG-TERM LIABILITIES
Long-Term Debt $3.350M $3.310M
YoY Change 1.21% 3.76%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.350M $3.310M
YoY Change 1.21% 3.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.24M $11.13M
Total Long-Term Liabilities $3.350M $3.310M
Total Liabilities $15.65M $14.44M
YoY Change 8.4% 7.98%
SHAREHOLDERS EQUITY
Retained Earnings -$119.2M -$116.8M
YoY Change 2.01%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.64M -$14.41M
YoY Change
Total Liabilities & Shareholders Equity $10.41K $85.08K
YoY Change -87.77% -96.17%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$517.7K -$630.2K
YoY Change -17.85% -24.35%
Depreciation, Depletion And Amortization $436.00 $502.00
YoY Change -13.15% -99.34%
Cash From Operating Activities -$125.6K -$226.1K
YoY Change -44.44% -34.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $22.85K
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 55.11K 120.4K
YoY Change -54.21% -35.75%
NET CHANGE
Cash From Operating Activities -125.6K -226.1K
Cash From Investing Activities
Cash From Financing Activities 55.11K 120.4K
Net Change In Cash -70.52K -105.8K
YoY Change -33.33% -33.45%
FREE CASH FLOW
Cash From Operating Activities -$125.6K -$226.1K
Capital Expenditures
Free Cash Flow -$125.6K -$226.1K
YoY Change -44.44% -34.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103597095
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103540352
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13460
CY2017Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2017Q3 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
CY2017Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
CY2017Q3 bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
CY2017Q3 bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
CY2017Q3 bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2017Q3 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
CY2017Q3 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2017Q3 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
8854488
CY2017Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
8796322
CY2017Q3 bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
39312
CY2016Q3 bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
90000
CY2017Q3 bnet Sale Of Units Value
SaleOfUnitsValue
39312
CY2017Q3 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2017Q3 bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
1.21
CY2017Q3 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
23189
CY2016Q3 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
75374
CY2017Q3 bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P3Y36D
CY2017Q3 bnet Weighted Average Shares For Fully Vested Stock Bonuses
WeightedAverageSharesForFullyVestedStockBonuses
CY2016Q3 bnet Weighted Average Shares For Fully Vested Stock Bonuses
WeightedAverageSharesForFullyVestedStockBonuses
600000
CY2017Q3 bnet Working Capital
WorkingCapital
-12236000
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
922180
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
865841
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2792997
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2792561
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55106
CY2016Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120350
CY2017Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3706
CY2017Q3 us-gaap Assets
Assets
10405
CY2017Q2 us-gaap Assets
Assets
84530
CY2017Q3 us-gaap Assets Current
AssetsCurrent
7649
CY2017Q2 us-gaap Assets Current
AssetsCurrent
81338
CY2017Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2017Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72932
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170194
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2413
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64418
CY2017Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-70519
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-105776
CY2017Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8400000
CY2017Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
100000
CY2017Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
40000
CY2017Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
40000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24809841
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24748213
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23573057
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24105532
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24043904
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22868748
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2017Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3346564
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3316060
CY2017Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
89763
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
88927
CY2017Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2328287
CY2016Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1657541
CY2017Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2107262
CY2017Q3 us-gaap Depreciation
Depreciation
436
CY2016Q3 us-gaap Depreciation
Depreciation
502
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11887752
CY2017Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2017Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2017Q3 us-gaap Minority Interest
MinorityInterest
56825
CY2017Q2 us-gaap Minority Interest
MinorityInterest
57332
CY2017Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
19500
CY2017Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2300
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
312117
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
424691
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1684562
CY2017Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
56339
CY2016Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
49861
CY2017Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
203400
CY2016Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
215400
CY2017Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3570
CY2016Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
661
CY2017Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
CY2016Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7500
CY2017Q3 us-gaap Interest Expense
InterestExpense
98439
CY2016Q3 us-gaap Interest Expense
InterestExpense
92764
CY2017Q3 us-gaap Interest Paid
InterestPaid
CY2016Q3 us-gaap Interest Paid
InterestPaid
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10405
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84530
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12244118
CY2016Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125625
CY2016Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-226126
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-507
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-534
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-517231
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-629666
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-98439
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92764
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
419299
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
537436
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-419299
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-537436
CY2017Q3 us-gaap Other Noncash Expense
OtherNoncashExpense
107231
CY2016Q3 us-gaap Other Noncash Expense
OtherNoncashExpense
101560
CY2017Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2380
CY2017Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1980
CY2017Q3 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
CY2016Q3 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
6008
CY2017Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3706
CY2016Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
CY2017Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2856
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6426
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22850
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
452000
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
761000
CY2017Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
39000
CY2017Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19500
CY2016Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2017 us-gaap Profit Loss
ProfitLoss
-2463000
CY2016 us-gaap Profit Loss
ProfitLoss
-4522000
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-517738
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-630200
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2756
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3192
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106746
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112243
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119194197
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118676966
CY2017Q3 us-gaap Revenues
Revenues
CY2016Q3 us-gaap Revenues
Revenues
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
21137
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
37412
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4520037
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.42
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
35000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
176575
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
81500
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4545037
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4545037
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.42
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.42
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
81500
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y255D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
25000
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
25000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.46
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.46
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y328D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y255D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
15900
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2017Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9211
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7677
CY2017Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7677
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-15637102
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-15176614
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15119282
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15580277
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24067093
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23544122
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24067093
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23544122

Files In Submission

Name View Source Status
0001079973-17-000642-index-headers.html Edgar Link pending
0001079973-17-000642-index.html Edgar Link pending
0001079973-17-000642.txt Edgar Link pending
0001079973-17-000642-xbrl.zip Edgar Link pending
bion_10q-093017.htm Edgar Link pending
bnet-20170930.xml Edgar Link completed
bnet-20170930.xsd Edgar Link pending
bnet-20170930_cal.xml Edgar Link unprocessable
bnet-20170930_def.xml Edgar Link unprocessable
bnet-20170930_lab.xml Edgar Link unprocessable
bnet-20170930_pre.xml Edgar Link unprocessable
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending